Navigation Links
Grifols implementa il suo primo sistema a carosello per la gestione automatizzata dell'inventario dei farmaci sperimentali presso la Emory University
Date:7/18/2013

la contabilità dei farmaci e la fatturazione. La combinazione di Vestigo e del sistema a carosello SencorpWhite offre una migliore conservazione dei farmaci sperimentali e una contabilità completa del farmaco. Grifols e il McCreadie Group (che produce Vestigo) hanno stretto una partnership commerciale per fornire al mercato dei farmaci sperimentali dell'ospedale una soluzione combinata per la gestione dell'inventario.

 Scott McCreadie, Dottore in Farmacia e Presidente del McCreadie Group, ha affermato: "È importante che Vestigo collabori con aziende come Grifols per chiudere il cerchio su conservazione e sicurezza dei farmaci nel mercato IDS. Questa soluzione combinata aiuterà IDS a soddisfare le proprie necessità in fatto di sicurezza dei farmaci e di obblighi normativi in modo sicuro ed efficiente."

Juan M. Cana, Direttore generale della Divisione Ospedaliera di Grifols, ha riconosciuto quanto sia importante per Grifols il miglioramento della gestione IDS, ed ha affermato: "Attualmente, la gestione IDS è spesso svolta manualmente, senza che vi sia tecnologia dedicata a questo importante settore della farmacia ospedaliera. Ogni giorno, IDS si trova ad affrontare molte sfide per sostenere le attività di ricerca di tutti i gruppi di ricerca e degli scienziati. Pensiamo che i tempi siano maturi per offrire una soluzione combinata con tecnologie che sono state appositamente ideate per aiutare l'IDS a supportare la gestione, il controllo e la conservazione dei farmaci sperimentali, la registrazione e la contabilità del farmaco, e al contempo aumentare l'efficienza del sistema. Riteniamo che tutto ciò possa cambiare radicalmente l'attività IDS."

Informazioni su Grifols

Grifols è una società mondiale del settore sanitario con una tradizione di 70 anni tesa al miglioramento e al benessere delle persone attraverso lo sv
'/>"/>

SOURCE Grifols
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug Designation for Cystic Fibrosis
2. Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency
3. Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt
4. Grifols Implements Its First Automated Inventory Management Carousel System for Investigational Pharmacies at Emory University
5. CalHIPSO Enrolls Over 7,700 Providers in EHR Implementation Program, Hits Other Key Milestones After First Two Years
6. Regional Medical Center at Memphis Completes Rapid Six-Month Implementation of Comprehensive Perioperative and Anesthesia Solution from Surgical Information Systems
7. Outpatient Imaging Affiliates Completes Phase I Of An Interoperability And Workflow Implementation With Compressus
8. Free Download -- QbD Implementation for Pharma Companies
9. Pharmaceutical Companies On Defense As Post-ACA Implementation Continues
10. Biotech industry has "implementation gap" around demonstrating the value of products under development
11. EarlySense System Implementation Shown to Reduce Falls, Decrease Transfers to Hospitals and Increase the Quality of Care for Elderly in Multi-Center Nursing Home Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ... (OFT) approval condition to the announced tender offer for all of ... As a result of the waiver, the transaction is no longer ... offer on January 24, 2014 following the currently scheduled expiration time, ...
(Date:1/15/2014)... PALM BEACH GARDENS, Fla. , Jan. 15, 2014  In an ... C. difficile and TB in ambulances and other transport vehicles, an ... being used by rescue personnel for the first time. ... coming in contact with these deadly pathogens, West Palm ...
(Date:1/15/2014)... , Jan. 15, 2014 The Cadence Fitness ... Fitness Center by the Medical Fitness Association, a non-profit ... achieve their full potential. The Cadence Fitness & Health ... western suburbs and second in the Chicagoland area. ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Superbugs No Longer Ride In Rescue Vehicles 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... 2010 STAAR Surgical Company (Nasdaq: STAA ... invasive ophthalmic products, today reported results for the third ... grew 6% to $13.2 million reflecting core product (IOLs ... decrease in defocused product revenue as compared to the ...
... Nov. 2, 2010 Kensey Nash Corporation (Nasdaq: ... investor conferences in November.   Michael Celano, ... presentation, at the Oppenheimer 21st Annual Healthcare Conference at ... at 2:10 p.m. (ET).  To hear the live webcast ...
Cached Medicine Technology:STAAR Surgical Reports Continued Double Digit Core Revenue Growth 2STAAR Surgical Reports Continued Double Digit Core Revenue Growth 3STAAR Surgical Reports Continued Double Digit Core Revenue Growth 4STAAR Surgical Reports Continued Double Digit Core Revenue Growth 5STAAR Surgical Reports Continued Double Digit Core Revenue Growth 6STAAR Surgical Reports Continued Double Digit Core Revenue Growth 7STAAR Surgical Reports Continued Double Digit Core Revenue Growth 8STAAR Surgical Reports Continued Double Digit Core Revenue Growth 9STAAR Surgical Reports Continued Double Digit Core Revenue Growth 10STAAR Surgical Reports Continued Double Digit Core Revenue Growth 11STAAR Surgical Reports Continued Double Digit Core Revenue Growth 12STAAR Surgical Reports Continued Double Digit Core Revenue Growth 13STAAR Surgical Reports Continued Double Digit Core Revenue Growth 14STAAR Surgical Reports Continued Double Digit Core Revenue Growth 15STAAR Surgical Reports Continued Double Digit Core Revenue Growth 16STAAR Surgical Reports Continued Double Digit Core Revenue Growth 17
(Date:7/10/2014)... For decades, health-conscious people around the globe have taken ... this was one of the paths to good health ... trials of antioxidant supplements have repeatedly dashed the hopes ... cancer risk. Virtually all such trials have failed ... fact, in several trials antioxidant supplementation has been linked ...
(Date:7/10/2014)... the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan ... patients a new therapeutic combination to combat resistant sarcomas. ... treatment could stabilize the growth of these tumors have ... of Cancer ., Sarcomas , Sarcomas are a ... several subtypes. It can affect from children to older ...
(Date:7/10/2014)... new drug could prove useful in treating small cell lung ... Scientists from the Cancer Research UK Manchester Institute, based at ... Research Centre, teamed up with experts at AstraZeneca, as part ... known as AZD3965 - on small cell lung cancer ... Cancer Research , also helps identify which patients are most ...
(Date:7/9/2014)... you think winning is one of the key determinants that ... with other mental bonuses ranked near the bottom of 81 ... 11 big fun factors, according to a new study. Despite ... comes to the "fun" factor, very little research had been ... elusive conceptuntil now. , The results of this study might ...
(Date:7/9/2014)... acute episodes of low back pain are not linked ... wind direction and precipitation. Findings published in Arthritis ... College of Rheumatology (ACR), indicate that the risk of ... or wind gusts, but was not clinically significant. ... everyone experiences low back pain at some point in ...
Breaking Medicine News(10 mins):Health News:How antioxidants can accelerate cancers, and why they don't protect against them 2Health News:New therapeutic combination to slow resistant sarcomas 2Health News:New drug active against most aggressive type of lung cancer cells 2Health News:Being a good sport ranks as the top 'fun' factor in study of youth sports 2Health News:Being a good sport ranks as the top 'fun' factor in study of youth sports 3Health News:Low back pain? Don't blame the weather 2
... 27 Attorney General Michael,B. Mukasey will deliver the ... Ceremony and remarks on Justice,Department nationwide efforts to combat ... be held on WEDNESDAY, MAY 28, 2008., WHO: ... WHEN: WEDNESDAY, MAY 28, 2008, 1:00 P.M. ...
... Fla. Once heralded as a promising obesity treatment, ... discovered overweight patients were resistant to its effects. But ... seems to revive the hormones ability to fight fat ... The combination of leptin and a modest dose of ...
... Finer Senior Living Expected in Coming Years, SANTA ... and scenery at Varenna. Oakmont Senior Living LLC did ... that benefits from 25 years,of experience in every facet ... new continuing care residential community sets a grand,and unparalleled ...
... is not associated with a reduced risk of prostate ... 27 in the Journal of the National Cancer ... of vitamin D may reduce the risk of prostate ... have reported inconsistent results. , In a nested case-control ...
... finds evidence of slight link between higher concentrations, aggressive ... Men with a high blood concentration of vitamin D ... Cancer Institute researchers report. , Previous laboratory studies had ... prostate cancer risk, but epidemiological studies of that association ...
... completely unexpected way that the brain repairs nerve damage, wherein ... neurons. , Astrocytes are a type of support cell in ... is to chew up damaged nerves during brain injury and ... Roger Chung and colleagues have now found that astrocytes have ...
Cached Medicine News:Health News:Combining exercise with hormone could prevent weight gain 2Health News:Combining exercise with hormone could prevent weight gain 3Health News:Sonoma Developer Oakmount Senior Living Marries Architecture With Nature to Recreate Tuscany at Varenna 2Health News:Sonoma Developer Oakmount Senior Living Marries Architecture With Nature to Recreate Tuscany at Varenna 3Health News:No association found between vitamin D concentration in blood and risk of prostate cancer 2Health News:Vitamin D Status Not Associated With Lower Prostate Risk 2
Intended for the quantitative determination of iron in serum. Reaction: Endpoint. Wavelength: 595 nm. Linearity: 500 g/dL (89.5 mol/L). Two vials, liquid reagents....
HDL Cholesterol (PEG) Precip. Reagent + 5 ml of 50 mg/dl cholesterol std....
Intended for the in vitro precipitation of very low density and low density lipoproteins in serum or plasma. Single vial, dry powder precipitating reagent. Total cholesterol reagent not included....
Ammonia reagent is used for the quantitative and enzymatic determination of ammonia in human plasma....
Medicine Products: